Common genetic polymorphisms ans susceptibility genes as predictors of menopausal hormone therapy-related brest cancer risk and adjuvant tamoxifen therapy outcome
JavaScript is disabled for your browser. Some features of this site may not work without it.
Common genetic polymorphisms ans susceptibility genes as predictors of menopausal hormone therapy-related brest cancer risk and adjuvant tamoxifen therapy outcome